Hydrea and Infusion related reaction - a phase IV clinical study of FDA data

Summary:

Infusion related reaction is reported as a side effect among people who take Hydrea (hydroxyurea), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Mylotarg, and have Acute myeloid leukaemia.

The phase IV clinical study analyzes which people have Infusion related reaction when taking Hydrea. It is created by eHealthMe based on reports of 8,922 people who have side effects when taking Hydrea from the FDA, and is updated regularly.

What is Hydrea?

Hydrea has active ingredients of hydroxyurea. It is often used in polycythemia vera. eHealthMe is studying from 9,083 Hydrea users. Check the latest studies of Hydrea.

What is Infusion related reaction?

Infusion related reaction is found to be associated with 1,530 drugs and 1,350 conditions by eHealthMe. Check the latest studies of Infusion related reaction.

On Jun, 17, 2026

8,922 people reported to have side effects when taking Hydrea.
Among them, 22 people (0.25%) have Infusion related reaction.

Could Hydrea cause Infusion related reaction?

Among these 22 people:

How long have people been on Hydrea when they have Infusion related reaction? *

What is the gender of people who have Infusion related reaction when taking Hydrea? *

female: 61.11 %
male: 38.89 %

What is the age of people who have Infusion related reaction when taking Hydrea? *

What are other drugs people take besides Hydrea? *

Mylotarg: 10 people, 45.45%
Mitoxantrone: 5 people, 22.73%
Cytarabine: 5 people, 22.73%
Tylenol: 3 people, 13.64%
Paracetamol: 3 people, 13.64%
Imuran: 3 people, 13.64%
Inflectra: 3 people, 13.64%
Venlafaxine Hydrochloride: 3 people, 13.64%
Mirtazapine: 3 people, 13.64%
Clopidogrel: 3 people, 13.64%

What are other side effects people have besides Infusion related reaction? *

Fever: 6 people, 27.27%
Febrile Neutropenia (fever with reduced white blood cells): 6 people, 27.27%
Disease Progression: 5 people, 22.73%
Joint Pain: 5 people, 22.73%
Thrombocytopenia (decrease of platelets in blood): 4 people, 18.18%
Constipation: 3 people, 13.64%
Dyspnea Exertional: 3 people, 13.64%
Heart Rate Increased: 3 people, 13.64%
High Blood Pressure: 3 people, 13.64%
Chest Pain: 3 people, 13.64%

What are the existing conditions these people have? *

Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 12 people, 54.55%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 3 people, 13.64%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 4.55%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 1 person, 4.55%
Depression: 1 person, 4.55%
Cerebral Infarction (less blood supply to brain resulting tissue damage): 1 person, 4.55%
Cerebral Haemorrhage (bleeding within the brain): 1 person, 4.55%
Arrhythmias (irregular heartbeat): 1 person, 4.55%

* Approximation only. Some reports may have incomplete information.

Do you take Hydrea and have Infusion related reaction?

- Check whether Infusion related reaction is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Hydrea:

Hydrea (9,083 reports)

Browse all side effects of Hydrea:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Infusion related reaction:

Infusion related reaction (1,530 drugs)

Browse all the conditions that are associated with Infusion related reaction:

Infusion related reaction (1,350 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on hydroxyurea (the active ingredients of Hydrea) and Hydrea (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.